Penn Brain Tumor Retreat

Emerging Concepts in the Management of Glioblastoma: 'From Temozolomide to Tumor Treating Fields'

4:00 PM Registrant check-in opens

4:45 PM Cocktails & Dinner

5:55 PM Welcome & Opening Remarks

Mitchell Schnall, MD, PhD, FACR

6:00 PM CAR T Cells for Glioblastoma: Update and Future Directions

Donald M. O'Rourke, MD

6:15 PM The Penn Brain Tumor Center: Innovation Within and Outside of the Operating Room

Steven Brem, MD

6:30 PM From TMZ to Tumor Treating Fields – How much progress have we made in the management of

malignant gliomas?

Roger Stupp, MD

7:15 PM Neuro-oncologic Imaging: Radiogenomics, Biomarkers & Response Assessment

Suyash Mohan, MD, PDCC

7:30 PM Advances in Computational Neuro-Oncology: Implications for Precision Diagnostics & Personalized

Therapeutics

Christos Davatzikos, PhD

7:40 PM Break

7:50 PM Collaborating Across the Divide to Improve Education, Research, Patient Survivorship, and Best

Clinical Practices

Na Tosha N. Gatson, MD, PhD

8:05 PM Of Fields and Phantoms: Using Realistic Computational Phantoms to Improve Delivery of Tumor

Treating Fields

Ze'ev Bomzan, PhD

8:20 PM Brain Tumor Clinical Trials at Penn: An Overview

Lisa Desiderio, RT (R) (MR) CCRC

Eileen Maloney Wilensky, MSN, ACNP-BC

8:30 PM Panel Discussion

Moderators: Robert A. Lustig, MD, FACR and David Mankoff, MD, PhD

8:40 PM Closing Remarks

Laurie A. Loevner, MD

8:45 PM Networking, Coffee & Dessert

Back to Top